Georgia CTSA COVID-19 Response
Georgia CTSA took an active role in monitoring the COVID-19 pandemic and sharing important news updates.
Previous Events and Special Webinars
Blue Sky Groups
- Vaccine Development and Testing
- COVID-19 Vaccine Hesitancy
- Post-Acute Sequelae of SARS-CoV2
- COVID–19 and Cardiovascular Complications
- COVID-19 and Health Equity
- Brain Health and COVID 19: Part 1
- Brain Health and COVID 19: Part 2
Special COVID Webinars
- Managing Virtual Teams
- Community Engagement in the Era of COVID-19: Opportunities, Challenges, and Lessons Being Learned
- Managing Lab Trainees During this Unprecedented Time
- Managing Clinical Trainees During This Time
- Ramping Down Clinical Trials
Featured News
- Georgia CTSA Clinical Research Centers Director Recognized for Achievements During COVID-19 and Beyond
- Georgia CTSA Leaders Receive Nearly $20M NIH Grant as Part of Long COVID Nationwide Study
- ‘What’s Your Why?’ Georgia CEAL Ad Campaign to Reduce COVID-19 Vaccine Hesitancy
- Researchers Awarded NIH Grant to Conduct COVID-19 Surveillance Through Detection of SARS CoV-2 in Wastewater
- Vital Role of RADx Tech Team in Expediting Evaluations of COVID-19 Testing Devices
- Georgia CTSA Recruitment Center Helps Research Team Attain Goals for COVID-19 Pandemic Impact Survey
- GCRCs Staff Help Emory Healthcare Administer COVID-19 Vaccine to Over 100,000 People in Georgia
- Georgia CTSA Investigators Release Viewpoint on Long-term Health Consequences of COVID-19
- Georgia CTSA Leaders Provide Recommendations for Community Engagement of African Americans in COVID-19 Era
- Georgia CTSA Leader Discusses Importance of COVID-19 Trials on NPR Affiliate
- Outstanding Results from Phase 3 COVID-19 Vaccine Trial Led by Former Georgia CTSA KL2 Scholar
- Georgia CTSA Leader Heads NIH’s Georgia CEAL to Address COVID-19 Disparities
- Community Engagement Alliance (CEAL) Against COVID-19 Disparities
- NIH Delivering New COVID-19 Tests Validated by Georgia CTSA Leaders
- Georgia CTSA Leads Serosurvey for CDC and FEMA COVID-19 Responders
- Georgia CTSA Investigators Encouraged by COVID-19 Vaccine Trial
- NIH Launches National COVID Cohort Collaborative (N3C)
- Georgia CTSA Leaders to Begin Phase 1 Validation for National COVID-19 Tests
- Former Georgia CTSA KL2 Scholar Helps Lead COVID-19 Research Efforts
- Georgia CTSA CPTR Graduate's Anti-Inflammatory Drug Selected for International Phase 3 COVID-19 Trial
- COVID-19 Prevention Measures Advocated by Georgia CTSA MSCR Grad
- Georgia CTSA MSCR Grad Helps Develop Best Practices for COVID ICU
- Georgia CTSA Former Trainee Scales Up In-House COVID-19 Test
- Former Georgia CTSA Trainee Helps Lead ICU Response to COVID-19
- Georgia CTSA MSCR Graduates on Front Line of COVID-19 Battle
- Georgia CTSA Rapid Response Team Coordinates 48-Hour Approval for Treatment of Coronavirus Patient
- Georgia CTSA Leader Named to Georgia's Coronavirus Task Force